Company / Revenue
AbbVie Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$61.2B
FY2025
5-year range
$54.3B / $61.2B
FY2021-FY2025
Trend
+8.6%
vs FY2024
Sector context
#5 of 153
Health Care
What the data says
Among 153 Health Care companies, AbbVie is in the top 3% for revenue. Improved from $54.3B to $61.2B over the past 2 years.
Based on SEC 10-K filings.
$61.2B in FY2025 with a 5-year CAGR of +6.0%. Top quartile in the Health Care sector.
Improved from $54.3B to $61.2B over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +1.8%
- 5-Year CAGR
- +6.0%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 153This company $61.2B Sector average $4.5B
▼
+1253.8% above sector average
Key checks
Key Insights
- 5-year CAGR of +6.0%, indicating consistent growth.
- In FY2025, revenue increased 8.6% year-over-year.
- Ranks #5 out of 153 companies in the Health Care sector.
- Lowest revenue in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $61.2B | +8.6% |
| FY2024 | $56.3B | +3.7% |
| FY2023 | $54.3B | -6.4% |
| FY2022 | $58.1B | +3.3% |
| FY2021 | $56.2B | +22.7% |
| FY2020 | $45.8B | +37.7% |
| FY2019 | $33.3B | +1.6% |
| FY2018 | $32.8B | +16.1% |
| FY2017 | $28.2B | +10.1% |
| FY2016 | $25.6B | +12.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026